AMLOTENS

This brand name is authorized in Hong Kong, Singapore, Tunisia

Active ingredients

The drug AMLOTENS contains one active pharmaceutical ingredient (API):

1 Amlodipine
UNII FAS0DJC51V - AMLODIPINE MESYLATE MONOHYDRATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

Read about Amlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C08CA01 Amlodipine C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 58071, 58072
Country: SG Health Sciences Authority Identifier(s): 13784P, 13785P, 14255P, 14256P
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 9044401, 9044402, 9044403, 9044404

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.